Structure of the 70S Ribosome from the Human Pathogen Acinetobacter baumannii in Complex with Clinically Relevant...

Area of Science:

• Microbiology
• Structural Biology
• Drug Discovery

Background:

• Acinetobacter baumannii is a significant cause of hospital-acquired infections.
• Multidrug-resistant (MDR) strains pose a therapeutic challenge.
• Amikacin and tigecycline are key ribosome-targeting antibiotics for treating these infections.

Purpose of the Study:

• To elucidate the high-resolution structures of the 70S ribosome from A. baumannii in complex with amikacin and tigecycline.
• To identify unique structural features of A. baumannii ribosomes compared to other bacteria.
• To understand the precise mechanisms of amikacin and tigecycline binding.

Main Methods:

• Cryoelectron microscopy (cryo-EM) was employed to determine the structures.
• Comparative structural analysis was performed between A. baumannii ribosomes and those from other bacterial species.

Main Results:

• High-resolution structures of A. baumannii 70S ribosome-antibiotic complexes were obtained.
• Unique structural characteristics were identified at functionally critical sites, including the polypeptide exit tunnel and subunit interface.
• The specific binding sites and modes of action for amikacin and tigecycline were revealed.

Conclusions:

• The determined structures provide a detailed molecular understanding of antibiotic action against A. baumannii.
• Unique ribosomal features offer potential targets for novel therapeutic strategies.
• This work is foundational for designing next-generation inhibitors to combat MDR A. baumannii infections.